Therapeutic Asset Ratings

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Montelukast Asthma	Kafrelsheikh University	P4	BBB (73)
Nepenthe Post-Operative Pain, Non-Human Animal	IVO JURISIC	P4	BBB (73)
Ningmitai Chronic Prostatitis	Xintian Pharmaceutical	P4	BBB (73)
Nintedanib Idiopathic Pulmonary Fibrosis	Mannkind Corporation	P4	BBB (73)
Normal Human Serum Albumin Cirrhosis Of Liver	King George's Medical University	P4	BBB (73)
Olaparib Breast Carcinoma	The Netherlands Cancer Institute	P4	BBB (73)
Orelabrutinib Marginal Zone Lymphoma	Henan Cancer Hospital	P4	BBB (73)
Orlistat Type 2 Diabetes Mellitus	Affiliated Hospital of Nantong University	P4	BBB (73)
Oxaliplatin Colonic Neoplasm	First Affiliated Hospital of Guangxi Medical University	P4	BBB (73)
Oxaliplatin Metastasis From Malignant Tumor Of Colon	Fudan University	P4	BBB (73)
Oxodotreotide Digestive System Neuroendocrine Neoplasm	National Cancer Institute (NCI)	P4	BBB (73)
Oxycodone Chronic Pain Syndrome	Mayo Clinic	P4	BBB (73)
Phentermine Obesity Disorder	Russell McCulloh, MD	P4	BBB (73)
Pioglitazone Metabolic Dysfunction-Associated Steatotic Liver Disease	Badr University	P4	BBB (73)
Pioglitazone Type 2 Diabetes Mellitus	Seoul National University Bundang Hospital	P4	BBB (73)
Prednisone Hepatosplenic T-Cell Lymphoma	City of Hope Medical Center	P4	BBB (73)
Prednisone Skin Cancer	Dana-Farber Cancer Institute	P4	BBB (73)
Prednisone Prostate Carcinoma	Mayo Clinic	P4	BBB (73)
Pregabalin Chronic Pain Syndrome	Federico II University	P4	BBB (73)
Pregabalin Neuralgia	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P4	BBB (73)
Propofol Alzheimer Disease	Nyree Penn	P4	BBB (73)
Propofol Morbid Obesity	G.Gennimatas General Hospital	P4	BBB (73)
Prucalopride Inflammatory Bowel Disease	Region Skane	P4	BBB (73)
Quetiapine Bipolar I Disorder	Massachusetts General Hospital	P4	BBB (73)
Ramifentanyl Morbid Obesity	Hospital dos Lusíadas	P4	BBB (73)

Showing 626 to 650 of 42,327 assets

PreviousPage 26 of 1694Next